|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Sales, general, and administrative | |||||
| Research and development | |||||
| Acquisition-related amortization, impairment, and remeasurement (Note 17) | |||||
| Operating loss | |||||
| Interest expense, net | |||||
| Other (expense) income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of common shares: | |||||
| Basic | |||||
| Diluted | |||||
| Other comprehensive income (loss), before tax | |||||
| Unrealized loss on debt securities | |||||
| Currency translation adjustment | |||||
| Other comprehensive income (loss), before tax | |||||
| Other comprehensive income (loss), net of tax | |||||
| Comprehensive loss | |||||
Loading...